Purple Biotech Ltd. (PPBT)
NASDAQ: PPBT
· Real-Time Price · USD
2.43
0.12 (5.19%)
At close: Aug 15, 2025, 3:59 PM
2.28
-6.17%
After-hours: Aug 15, 2025, 04:48 PM EDT
5.19% (1D)
| Bid | 2.14 |
| Market Cap | 32.17K |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -3.93M |
| EPS (ttm) | -45.9 |
| PE Ratio (ttm) | -0.05 |
| Forward PE | -3.42 |
| Analyst | Buy |
| Ask | 2.63 |
| Volume | 9,500 |
| Avg. Volume (20D) | 101,793 |
| Open | 2.21 |
| Previous Close | 2.31 |
| Day's Range | 2.21 - 2.43 |
| 52-Week Range | 2.00 - 13.95 |
| Beta | -0.58 |
About PPBT
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol PPBT
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for PPBT stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts3 months ago
-5.14%
PPBT stock has given up its prior gain. Purple Bio...
Unlock content with
Pro Subscription
3 months ago
-5.14%
Purple Biotech shares are trading higher after the company's CM24 showed up to a 90% reduction in the death risk for pancreatic cancer patients and announced it will commence a Phase 2b study.
